日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants

克列维单抗在早产儿和足月儿中的群体药代动力学

Hu, Ziheng; Hellmann, Farina; Zang, Xiaowei; Plock, Nele; Parmar, Keyur; Railkar, Radha A; Cheung, S Y Amy; Maas, Brian M; Gheyas, Ferdous

Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab Trial Are Associated With RSV Exposure Beyond Day 150

在一项针对婴儿的 Clesrovimab 1b/2a 期试验中,高滴度抗药抗体的产生与出生后 150 天以上的 RSV 暴露相关。

Thambi, Nithya; Phuah, Jia Yao; Staupe, Ryan P; Tobias, Lori M; Cao, Yu; McKelvey, Troy; Railkar, Radha A; Aliprantis, Antonios O; Arriola, Carmen Sofia; Maas, Brian M; Vora, Kalpit A

A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants

一项针对健康早产儿和足月儿的半衰期延长型呼吸道合胞病毒中和抗体Clesrovimab的1b/2a期试验

Madhi, Shabir A; Simões, Eric A F; Acevedo, Armando; Novoa Pizarro, Jose M; Shepard, Julie S; Railkar, Radha A; Cao, Xin; Maas, Brian M; Zang, Xiaowei; Krick, Andrea; Roadcap, Brad; Vora, Kalpit A; Aliprantis, Antonios O; Lee, Andrew W; Sinha, Anushua

167. Phase 3, Randomized, Controlled Trial Evaluating Safety, Efficacy, and Pharmacokinetics (PK) of Clesrovimab in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease

167. 一项评估 Clesrovimab 在患严重呼吸道合胞病毒 (RSV) 疾病风险增加的婴幼儿中的安全性、有效性和药代动力学 (PK) 的 3 期随机对照试验

Ganchi, Feroz Abubaker; Hardcastle, Timothy Craig; Zar, Heather J; Bont, Louis J; Manzoni, Paolo; Munoz, Flor M; Ramilo, Octavio; Chen, Po-Yen; Novoa Pizarro, Jose M; Ordonez, Gustavo A; Tsolia, Maria; Tapiero, Bruce; Acuña, Mirta; Castellanos, Javier M; Meyer, Michael; Morioka, Ichiro; Chen, Ziqiang; Railkar, Radha A; Zang, Xiaowei; Krick, Andrea L; Lee, Andrew W; Castagnini, Luis A; Sinha, Anushua

Bacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancer

在患有高级别 BCG 难治性非肌层浸润性膀胱癌的成人患者中,卡介苗 (BCG) 联合 PANVAC™ 与单独使用 BCG 的疗效比较

Ho, Matthew; Lazarovich, Alon; Saoud, Ragheed; Dahmen, Aaron; Tremblay, Samuel; Telfer, Siobhan; Maruf, Mahir; Singer, Eric A; Weiss, Robert E; Jang, Thomas L; Elsamra, Sammy E; Merino, Maria; Dolan, Rebecca; Valera, Vladimir; Rodriquez, Beatriz Walter; Railkar, Reema; Bellfield, Sonia; Stamatakis, Lambros; Shih, Joanna; Donahue, Renee N; Navarro, Cesar Pico; Apolo, Andrea B; Gulley, James L; Schlom, Jeffrey; Agarwal, Piyush K

Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis

预测中和呼吸道合胞病毒(RSV)抗体预防效果的正向和反向转化方法

Maas, Brian M; Lommerse, Jos; Plock, Nele; Railkar, Radha A; Cheung, S Y Amy; Caro, Luzelena; Chen, Jingxian; Liu, Wen; Zhang, Ying; Huang, Qinlei; Gao, Wei; Qin, Li; Meng, Jie; Witjes, Han; Schindler, Emilie; Guiastrennec, Benjamin; Bellanti, Francesco; Spellman, Daniel S; Roadcap, Brad; Kalinova, Mariya; Fok-Seang, Juin; Catchpole, Andrew P; Espeseth, Amy S; Stoch, S Aubrey; Lai, Eseng; Vora, Kalpit A; Aliprantis, Antonios O; Sachs, Jeffrey R

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults

一项 1 期随机、安慰剂对照研究,旨在评估基于 mRNA 的 RSV 融合前 F 蛋白疫苗在健康青年和老年人群中的安全性和免疫原性。

Aliprantis, Antonios O; Shaw, Christine A; Griffin, Paul; Farinola, Nicholas; Railkar, Radha A; Cao, Xin; Liu, Wen; Sachs, Jeffrey R; Swenson, Christine J; Lee, Heather; Cox, Kara S; Spellman, Daniel S; Winstead, Colleen J; Smolenov, Igor; Lai, Eseng; Zaks, Tal; Espeseth, Amy S; Panther, Lori

Antisolvent precipitative immobilization of micro and nanostructured griseofulvin on laboratory cultured diatom frustules for enhanced aqueous dissolution

在实验室培养的硅藻壳上进行微结构和纳米结构灰黄霉素的抗溶剂沉淀固定,以增强其水溶性

Megha Thakkar, Mohammad Saiful Islam, Aditya Railkar, Somenath Mitra

Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc

蛋白酶体抑制通过下调 p62 和 c-Myc 破坏富马酸水合酶缺陷肿瘤的代谢

Carole Sourbier, Christopher J Ricketts, Pei-Jyun Liao, Shingo Matsumoto, Darmood Wei, Martin Lang, Reema Railkar, Youfeng Yang, Ming-Hui Wei, Piyush Agarwal, Murali Krishna, James B Mitchell, Jane B Trepel, Len Neckers, W Marston Linehan

Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)

使用联合光免疫疗法 (PIT) 治疗表皮生长因子受体 (EGFR) 和人类表皮生长因子受体 2 (HER2) 表达的膀胱癌

Mohammad R Siddiqui, Reema Railkar, Thomas Sanford, Daniel R Crooks, Michael A Eckhaus, Diana Haines, Peter L Choyke, Hisataka Kobayashi, Piyush K Agarwal